Novo Holdings leads EUR 7 million Seed investment in Danish start-up Bactolife

  • Danish start up developing novel biological solutions to reduce the risk of gastrointestinal infections in animals and humans
  • Novo Holdings is investing EUR 5 million of the total funding of EUR 7 million, which is one of the largest bioindustrials seed round investments in Europe
  • Novo Holdings’ ninth bioindustrials investment, now totalling over $130 million

Novo Seeds, the early stage investment and company creation team of Novo Holdings, today announced that it is leading a EUR 7 million seed investment into BactolifeTM, a Danish start up developing novel biological solutions to reduce the risk of gastrointestinal infections in animals and humans alongside existing private investors.

Read more

By Optimum

For more information about Optimum Strategic Communications, please get in touch

We'd love to hear from you...

GET IN TOUCH